NCT05883345|CompletedResults
Blood Tests for Gastritis and Gastric Neoplasms
Validation of Blood Test Finding for the Diagnosis of Gastritis and Gastric Neoplasms
Loading search results
Validation of Blood Test Finding for the Diagnosis of Gastritis and Gastric Neoplasms
Sponsor study identifier
observational
1,490
1 country
1
Study Start
May 1, 2023
Actual (reported)Primary Completion
August 30, 2024
Actual (reported)Study Completion
August 30, 2024
Actual (reported)Helicobacter pylori infection rate is decreasing in younger population; however, biennial gastroscopy is still recommended for all Koreans aged between 40 and 75 years. This study aimed to validate blood tests for gastric cancer screening according to the infection status of H. pylori (naive, current, and past infection).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 30, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2023
Actual (reported)May 9, 2023
Actual (reported)May 31, 2023
Actual (reported)August 30, 2024
Actual (reported)August 30, 2024
Actual (reported)March 11, 2025
Actual (reported)Significant Blood Test Findings Correlated With Gastric Neoplasms
Serum pepsinogen I/II ratios indicating the presence gastric neoplasms (Minimum and maximum ratios were 0.2 and 19.1, respectively. Lower ratios indicate worse outcome.)
15 months
Test Findings Correlated With the Presence of Gastric Neoplasms
15 months
Endoscopic biopsy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Adult population who visited our center for gastric cancer screening using serum assays
Konkuk University Medical Center
Seoul, 05030, South Korea
Lee SY, Moon HW, Ahn YS, Song JH, Kim JH, Sung IK. A Prospective Study on the Detection of Gastric Neoplasms Using Pepsinogen and Gastrin-17 Levels. Gut Liver. 2025 Jul 15;19(4):548-558. doi: 10.5009/gnl240544. Epub 2025 Apr 11.
Blood sample
Sun-Young Lee, MD, PhD
Department of Internal Medicine, Konkuk University School of Medicine
1,490 participants (actual enrollment reported by the registry).
First Submitted
May 9, 2023
First Posted
May 31, 2023
Study Start
May 1, 2023
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
August 30, 2024
Actual (reported)Study Completion
August 30, 2024
Actual (reported)Last Updated
March 11, 2025
Results First Posted
March 11, 2025
Record last verified: 2025-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: